A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2004
11/03/2004	EP1286957B1 Diphenylmethane derivatives
11/03/2004	EP1261609B1 Triazolotriazinones and the use thereof
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004	EP1207884B1 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes
11/03/2004	EP1191028B1 Tricyclic compounds having spiro union
11/03/2004	EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004	EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004	EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/03/2004	EP0694042B1 Inhibitor of vascular endothelial cell growth factor
11/03/2004	CN1543500A Cardiomyocyte precursors from human embryonic stem cells
11/03/2004	CN1543466A New use of specific cyclolignans
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543453A 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1543358A Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/03/2004	CN1543352A Method and material for treating immune diseases
11/03/2004	CN1543349A Enhanced drug delivery in transdermal systems
11/03/2004	CN1543346A Novel compounds
11/03/2004	CN1543343A Preparation and diabetic use of gibberellins
11/03/2004	CN1543342A Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/03/2004	CN1542010A Azolo triazines and pyrimidines
11/03/2004	CN1542009A Preparation method and use of dipyridanmole derivative
11/03/2004	CN1541714A Gene transfer-mediated angiogenesis therapy
11/03/2004	CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels
11/03/2004	CN1541693A Chinese traditional medicine decoction for treating heart disease
11/03/2004	CN1541690A Chinese traditional medicine preparation Qimaishen for treating viral myocarditis and its manufacturing method
11/03/2004	CN1541686A Ginkgo extracturm, drink and preparation thereof
11/03/2004	CN1541681A Hypertension treating traditional Chinese medicine preparation and its preparing process
11/03/2004	CN1541677A Medicinal composition for treating coronary disease and its preparation and application
11/03/2004	CN1541671A Medicine for treating angina pectoris and its preparation and application
11/03/2004	CN1541670A Decoction for treating cardiovascular and cerebrovascular disease and its preparation
11/03/2004	CN1541668A Osteopathy treating ointment
11/03/2004	CN1541653A Kudzu vine capsule for regulating blood pressure and blood fat, its preparation process
11/03/2004	CN1173992C Hybrid peptide with vascularization inhibiting activity
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173973C Benzocarbazole and indenoindole derived estrogenic agents
11/03/2004	CN1173970C Tetrahydroquinoline derivatives as glycine antagonists
11/03/2004	CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004	CN1173967C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
11/03/2004	CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/03/2004	CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/03/2004	CN1173926C Substituted 2-phenyl-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system and pharmaceutical compositions containing them
11/03/2004	CN1173745C Use of chemically modified methioninase in anti-methionine and anti-homocysteine chemotherapy
11/03/2004	CN1173727C Chinese medicine liquor for clearing and activating main and collateral channels, and its preparation method
11/03/2004	CN1173719C Preparation of hemorrhoids treating capsule
11/03/2004	CN1173714C Chinese-medicinal capsule for preventing and treating cerebral apoplexy
11/03/2004	CN1173710C Treatment of congestive heart failure by pretreated autologous blood
11/03/2004	CN1173707C Medicinal composition containing baicalin and caffoeoylchinic acid
11/03/2004	CN1173700C Compositions and methods for amelioration of human female sexual dysfunction
11/03/2004	CN1173696C Use of sibutramine analogues to lower lipid levels
11/03/2004	CN1173695C Controlled release and odor masking oral pharmaceutical compositions
11/02/2004	US6812364 Central nervous system disorders; psychological disorders; anticancer agents
11/02/2004	US6812257 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
11/02/2004	US6812256 Reducing weight in mammals; anorectic action
11/02/2004	US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004	US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004	US6812225 Pyschological disorders; antidepressants
11/02/2004	US6812213 Steroidal sapogenins and their derivatives for treating alzheimer's disease
11/02/2004	US6812210 Urocortin-III and uses thereof
11/02/2004	US6812203 Treatment of cd40 and/or nf-kb related diseases, antiinflammatory, antitumor
11/02/2004	US6812034 Diagnosing calcification of arteries; obtain blood sample, screen for the presence of fetuin-mineral complex in blood, amplified concentration of fetuin complex indicates calcification of arteries and other soft tissues
11/02/2004	US6812014 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	US6811777 Compositions and minimally invasive methods for treating incomplete connective tissue repair
11/02/2004	US6811768 Use of inhaled NO as anti-inflammatory agent
11/02/2004	US6811767 Liquid droplet aerosols of nanoparticulate drugs
11/02/2004	CA2338704C Oral liquid mucoadhesive compositions
11/02/2004	CA2315614C Pyrazoles
11/02/2004	CA2296970C Neuropeptide y antagonists
11/02/2004	CA2282279C Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
11/02/2004	CA2115536C Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives
11/02/2004	CA2094806C Aminosulfonyl urea acat inhibitors
11/02/2004	CA2074039C Antihypertensive combination
10/2004
10/28/2004	WO2004092388A1 Vector
10/28/2004	WO2004092379A2 Method for treatment of angiogenic disorders
10/28/2004	WO2004092378A2 Method for treatment of cancerous angiogenic disorders
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004092186A1 Phosphates of secondary alcohols
10/28/2004	WO2004092179A1 Spiro derivative, production process, and antioxidant
10/28/2004	WO2004092169A1 Spiropiperidine compound and medicinal use thereof
10/28/2004	WO2004092163A1 Phenylazole compound, production process, and antioxidant drug
10/28/2004	WO2004092153A1 Diamine derivative, production process, and antioxidizing drug
10/28/2004	WO2004092147A1 M-stage kinesin inhibitor
10/28/2004	WO2004092136A1 Nitrogenous heterocyclic compound and use thereof
10/28/2004	WO2004092128A1 Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile
10/28/2004	WO2004092117A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars
10/28/2004	WO2004091660A1 Lklf/klf2 gene expression promoter
10/28/2004	WO2004091645A2 Composition comprising rosmarinic acid, borneol and ginsenoside
10/28/2004	WO2004091632A1 A pharmaceutical composition containing an active agent having the effect of digitalis and a cgmp phosphodiesterase inhibitor
10/28/2004	WO2004091628A1 Receptor antagonist
10/28/2004	WO2004091614A2 Stabilized amlodipine maleate formations
10/28/2004	WO2004091608A1 Decreasing the incidence of atrial fibrillation (af) in patients with left ventricular dysfunction with ace inhibitors or angiotensin ii receptor antagonists
10/28/2004	WO2004091605A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
10/28/2004	WO2004091604A1 Compounds that modulate ppar activity and methods of preparation

1 ... 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 ... 1595